Barclays Boosts UnitedHealth Group (NYSE:UNH) Price Target to $560.00

UnitedHealth Group (NYSE:UNH) had its price objective upped by investment analysts at Barclays from $534.00 to $560.00 in a note issued to investors on Wednesday, Benzinga reports. The firm currently has an “overweight” rating on the healthcare conglomerate’s stock. Barclays‘s target price indicates a potential upside of 13.55% from the company’s current price.

UNH has been the topic of several other reports. Stephens reissued an “overweight” rating and set a $605.00 price objective on shares of UnitedHealth Group in a research note on Thursday, February 8th. Truist Financial restated a “buy” rating and set a $600.00 price target on shares of UnitedHealth Group in a report on Wednesday. TD Cowen cut their price objective on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a research note on Wednesday, April 10th. Finally, Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Four investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $569.68.

UnitedHealth Group Trading Up 3.0 %

Shares of UnitedHealth Group stock opened at $493.16 on Wednesday. The stock has a market capitalization of $454.66 billion, a PE ratio of 30.14, a P/E/G ratio of 1.28 and a beta of 0.54. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. The company’s fifty day simple moving average is $488.97 and its 200-day simple moving average is $515.22. UnitedHealth Group has a 1-year low of $436.38 and a 1-year high of $554.70.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. During the same period last year, the firm posted $6.26 earnings per share. UnitedHealth Group’s revenue for the quarter was up 8.6% compared to the same quarter last year. As a group, equities analysts anticipate that UnitedHealth Group will post 27.75 earnings per share for the current year.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in UNH. Richelieu Gestion SA acquired a new position in shares of UnitedHealth Group during the 4th quarter worth about $26,000. Robbins Farley purchased a new position in shares of UnitedHealth Group in the third quarter valued at approximately $25,000. CGC Financial Services LLC increased its position in shares of UnitedHealth Group by 1,000.0% during the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 50 shares in the last quarter. True Wealth Design LLC purchased a new position in UnitedHealth Group in the 4th quarter valued at $31,000. Finally, NewSquare Capital LLC grew its holdings in shares of UnitedHealth Group by 340.0% during the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after buying an additional 51 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.